Home » Topics » Regulatory » Patents

Patents
RSS

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.